Canada Life’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-33,457
| Closed | -$2.41M | – | 2642 |
|
|
2020
Q4 | $2.41M | Sell |
33,457
-4,893
| -13% | -$256K | ﹤0.01% | 1043 |
|
|
2020
Q3 | $1.75M | Sell |
38,350
-3,943
| -9% | -$165K | ﹤0.01% | 1134 |
|
|
2020
Q2 | $1.91M | Sell |
42,293
-2,788
| -6% | -$125K | ﹤0.01% | 1094 |
|
|
2020
Q1 | $1.73M | Buy |
45,081
+4,264
| +10% | +$196K | ﹤0.01% | 1020 |
|
|
2019
Q4 | $1.87M | Buy |
+40,817
| New | +$1.77M | ﹤0.01% | 1169 |
|
|
2019
Q3 | – | Sell |
-44,780
| Closed | -$2.16M | – | 2740 |
|
|
2019
Q2 | $2.16M | Buy |
+44,780
| New | +$2.35M | ﹤0.01% | 1135 |
|
|
2019
Q1 | – | Sell |
-43,802
| Closed | -$2.42M | – | 2788 |
|
|
2018
Q4 | $2.42M | Buy |
43,802
+4,289
| +11% | +$258K | 0.01% | 902 |
|
|
2018
Q3 | $2.54M | Sell |
39,513
-125
| -0.3% | -$6.97K | 0.01% | 1008 |
|
|
2018
Q2 | $1.78M | Buy |
39,638
+113
| +0.3% | +$4.51K | ﹤0.01% | 1253 |
|
|
2018
Q1 | $1.23M | Hold |
39,525
| – | – | ﹤0.01% | 1430 |
|
|
2017
Q4 | $1.18M | Sell |
39,525
-1,800
| -4% | -$52.1K | ﹤0.01% | 1466 |
|
|
2017
Q3 | $1.33M | Buy |
41,325
+626
| +2% | +$21.7K | ﹤0.01% | 1403 |
|
|
2017
Q2 | $1.36M | Buy |
40,699
+1,600
| +4% | +$47.7K | ﹤0.01% | 1382 |
|
|
2017
Q1 | $1.13M | Buy |
39,099
+1,227
| +3% | +$30.4K | ﹤0.01% | 1458 |
|
|
2016
Q4 | $843K | Buy |
37,872
+3,000
| +9% | +$58.7K | ﹤0.01% | 1544 |
|
|
2016
Q3 | $648K | Buy |
+34,872
| New | +$658K | ﹤0.01% | 1602 |
|
Other funds holding BEAT
Canada Life's BEAT Position: Q1 2021 in Review
Canada Life sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 33,457 shares — an estimated $2.41M sold.
Canada Life first reported a position in BEAT in Q3 2016 and held it in 16 quarters. The position peaked at $2.54M in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Canada Life reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Canada Life sold 33,457 BioTelemetry, Inc. shares in Q1 2021, an estimated $2.41M.
- Canada Life first reported a position in BioTelemetry, Inc. in Q3 2016 and held it in 16 quarters.
- Canada Life's BioTelemetry, Inc. position peaked at $2.54M in Q3 2018.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Canada Life's 13F filing for Q1 2021, filed 17 May 2021.